KA Imaging Launching Portable Dual-Energy X-ray Detector

For the first time, practitioners will be able to leverage dual-energy X-ray technology in a portable system. Canadian manufacturer KA Imaging is getting ready to launch Reveal, the world’s first dual-energy X-ray detector that can be taken to the bedside. “Due to...

CereHealth Showcases “Going Against the Norm” During the Society of Nuclear Medicine and Molecular Imaging’s Annual Meeting

CereHealth Corp., a recognized leader and innovator in biotechnology applications and advanced neurodiagnostics, announced that its FDA-cleared population template, an alternative to traditional normative datasets for quantitative analysis of clinical brain SPECT,...

VA Selects Philips to Create World’s Largest Tele-Critical Care System

Royal Philips has announced that the U.S. Department of Veterans Affairs (VA) has awarded a contract to Philips to expand VA’s tele-critical care program, creating the world’s largest system to provide veterans remote access to intensive care expertise, regardless of...

Hologic Launches Cart-Based Ultrasound System

Hologic Inc. has announced the U.S. launch of the SuperSonic MACH 40 ultrasound system, expanding the company’s suite of ultrasound technologies with its first premium, cart-based system. The new system features excellent image quality, standard-setting imaging modes...

Microbubbles and Ultrasound Can Help Treat Heart Attacks

CHICAGO–(BUSINESS WIRE)–Doctors are using microbubbles and ultrasound to treat heart attacks — deploying these traditional diagnostic tools in an attempt to reopen tiny blood vessels, reduce scar size and restore heart function, according to a study described Friday at a medical conference in Chicago.

“This study shows for the first time that microbubbles can be used to both diagnose and treat small vessel obstructions that block blood flow after a heart attack,” said Dr. Thomas Porter, who announced the study results at the 34th annual International Bubble Conference in Chicago. Dr. Porter also is Theodore F. Hubbard Distinguished Chair of Cardiology at the University of Nebraska Medical Center and a member of the Board of Directors of the International Contrast Ultrasound Society (ICUS).

Patients who had recently suffered heart attacks first received stents to open larger arteries, but micro-vessels frequently remained blocked, Dr. Porter said.

“Microvascular obstruction remains a major clinical problem even after successful stenting, involving up to nearly 70% of patients with larger heart attacks,” he added.

Dr. Porter and his team first used microbubbles to enhance ultrasound imaging and identify the remaining microvascular blockages. They subsequently used microbubbles with ultrasound in an attempt to open the “micro-blockages.”

Microbubble contrast agents are also sometimes known as ultrasound enhancing agents or ultrasound contrast agents. They generally are used for diagnostic purposes — that is, to improve the clarity and functionality of ultrasound imaging, allowing doctors to more accurately diagnose heart defects and cardiovascular disease, assess heart function, characterize tumors in the liver and other organs, follow the progression of gastro-intestinal disease and monitor therapy.

This study shows that microbubbles may have broader applications, potentially extending their use from diagnostics to therapy, according to Dr. Porter.



Submit a Comment

Your email address will not be published. Required fields are marked *